Home / Case Stories

Not "introducing resources" — end-to-end delivery

The hardest part of cross-border care isn't finding a hospital; it's linking consultation, plan, specialist, accompaniment, treatment and follow-up into a path that never drops the ball. Below are client-authorized, anonymized cases.

About this page The following are client-authorized, anonymized cases, used to illustrate our process and delivery. Individual experiences do not represent typical outcomes and are not a guarantee of results. Any medical figures are general background information; diagnosis, treatment and prognosis should be assessed in person by a licensed institution and physician.
Precision Checkup · Early Detection

Case 1 · A trip to Japan that found and resolved a 0.6cm early gastric cancer

Background

A Beijing entrepreneur, Mr. L, had a domestic checkup noting "rough gastric mucosa." While planning a trip to Japan, his wife contacted us to arrange a more detailed examination during the visit.

How we stepped in

  • Our Medical Director personally conducted the consultation, reviewing his prior checkup report;
  • A tailored examination plan was designed with a leading Japanese cancer institute, matched to the appropriate specialist professor;
  • After the client arrived and enjoyed sightseeing, a colleague visited his hotel to brief pre-exam preparation and precautions;
  • On the day, staff accompanied him throughout, easing language and process burdens.

Outcome

During the exam, the specialist used magnifying endoscopy + AI assistance to detect a 0.6cm early-stage cancer. Because it was caught early, the plan was ESD (endoscopic submucosal dissection) — a minimally-invasive procedure requiring no open surgery.

Background: for early gastric cancer meeting the criteria, minimally-invasive endoscopic treatment such as ESD can achieve very high cure rates — literature reports a 5-year survival of up to ~99%. Actual indications and prognosis must be assessed by the treating physician.

Experience highlight: travel and precision screening, combined naturally — from consultation to specialist to accompaniment — so that catching and treating an early cancer happened within a relaxed itinerary.

Regenerative / Immune · Post-Op

Case 2 · Personalized cell-immunotherapy for post-surgery relapse prevention

Background

A breast-cancer patient after surgery wished to pursue long-term relapse-prevention management beyond routine follow-up.

How we stepped in

  • Our clinical director reviewed her case and reports in detail;
  • A personalized plan was designed: storing NK cells at the clinic and reinfusing every six months for long-term intervention.

Outcome

Over 3 years to date, this client has shown no recurrence or metastasis during follow-up.

Note: cell immunotherapy is an adjunctive approach; efficacy varies by individual, and evidence levels and indications differ across studies and regions. This is a single-case follow-up result, not a typical outcome or a guarantee, and must be assessed by a licensed physician.*

* Any comparative data (e.g. post-op recurrence rates reported in the literature) is for research background only; refer to authoritative sources and the treating physician.

Why we can do this

Delivery comes from holding every link in hand

Medical consultation first

Our medical team assesses before any plan — not selling a procedure.

Top institutions & experts

Matched to leading hospitals and specialist professors.

Full accompaniment

From hotel briefing to exam day, easing language and process.

Long-term management

Follow-up and intervention continue after treatment.

Your situation deserves a tailored delivery plan too

Tell us about your or your family's health and needs. Our medical team assesses first, then maps a clear, actionable next step.

Book a 1:1 Consultation
Cases are client-authorized and anonymized, used to illustrate our process only. They do not represent typical outcomes and do not constitute medical advice, diagnosis, treatment, or any guarantee of results. Medical outcomes vary by individual. Regulations on medical information and advertising differ by country/region; diagnosis and treatment are subject to assessment by a licensed institution and physician.